QNCX 424B5 DEF-14A Report Oct. 17, 2025 | Alphaminr
Quince Therapeutics, Inc.

QNCX 424B5 Report ended Oct. 17, 2025

CIK: 1662774
Filing Type: 424B5
Report Date: 2025-10-17
Download URL: https://www.sec.gov/Archives/edgar/data/1662774/000119312525242511/d79739d424b5.htm
]]>
TABLE OF CONTENTS